| 摘要 |
The present invention relates to new 2-tolylmorpholine derivatives, namely, more precisely, (a) 2-p-tolyl-4-isopropylmorpholine and its addition salts, (b) 2-m-tolyl-4-methylmorpholine and its addition salts, (c) 2-p-tolyl-4-methylmorpholine and its addition salts, (d) 2-o-tolyl-4-tert.-butylmorpholine and its addition salts, (e) 2-p-tolyl-4-tert.-butylmorpholine and its addition salts, and (f) 2-(m-trifluoromethylphenyl)-2-hydroxy-4-ethylmorpholine and its addition salts. These new derivatives are useful in therapy, especially as agents active on the CNS. |
